Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Barbara, Coleman"'
Autor:
Charles M. Rudin, Malcolm V. Brock, Stephen B. Baylin, James G. Herman, Steven A. Belinsky, Michelle A. Rudek, Igor Espinoza Delgado, Salina Tsai, Beverly Lee, Noreli Franco, Craig M. Hooker, Kristen Rodgers, Rosa Sebree, Barbara Coleman, Ming Zhao, Sara C. Murphy, Frank P. Vendetti, John Wrangle, Rosalyn A. Juergens
mp3 file (49.6MB). Patients with recurrent metastatic non-small cell lung cancer have a morbid prognosis, but a new epigenetic therapy may have potential for this population. Cancer Discovery Editors-in-Chief Jose Baselga, M.D., Ph.D. and Lewis C. Ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::903e2d0eae26ec64c9c6ad1ff3eb7c7f
https://doi.org/10.1158/2159-8290.22529045
https://doi.org/10.1158/2159-8290.22529045
Autor:
Marc Miller, Barbara Coleman
Publikováno v:
Issues in Information Systems, Vol 6, Iss 1, Pp 217-223 (2005)
It is widely accepted that sustaining Business and Information Technology (IT) alignment is a complex task, due to the lack of appropriate alignment methodologies, rapid changes in running business processes and insufficient IT techniques to cope wit
Externí odkaz:
https://doaj.org/article/e289c1a6f561411a92d2b314878e9d07
Autor:
Edward Gabrielson, Xian Zhou, Christine L. Hann, Julie R. Brahmer, Gary L. Rosner, Barbara Coleman, Ronan J. Kelly, Michael Purtell, Patrick M. Forde, David S. Ettinger, Kristen A. Marrone
Publikováno v:
The Oncologist
Background In the absence of a targeted oncogenic driver mutation or high programmed death-ligand 1 expression, systemic therapy with platinum-based doublet chemotherapy with or without bevacizumab has been the standard treatment in advanced or metas
Publikováno v:
Journal of Applied Marketing Theory, Vol 1, Iss 1 (2010)
Websites and publicity in mass media are two commonly used marketing elements. However, it is unclear whether exposure to a website or publicity is most effective at influencing behavior. This research compares the effectiveness of a magazine publici
Externí odkaz:
https://doaj.org/article/35976838d5074a3f8965dd4e141e932a
Autor:
Megan Crofts, Barbara Coleman, Mark Gompels, Jeremy Horwood, Annette Billing, Margaret T. May, Joanna M Kesten, Charlotte F Davies
Publikováno v:
HIV Medicine
Autor:
Hayley E, Jones, Nicky J, Welton, A E, Ades, Matthias, Pierce, Wyn, Davies, Barbara, Coleman, Tim, Millar, Matthew, Hickman
Publikováno v:
Addiction (Abingdon, England)
Jones, H E, Welton, N J, Ades, A E, Pierce, M, Davies, W, Coleman, B, Millar, T & Hickman, M 2016, ' Problem drug use prevalence estimation revisited : heterogeneity in capture-recapture and the role of external evidence ', Addiction, vol. 111, no. 3, pp. 438-47 . https://doi.org/10.1111/add.13222
Jones, H E, Welton, N J, Ades, A E, Pierce, M, Davies, W, Coleman, B, Millar, T & Hickman, M 2016, ' Problem drug use prevalence estimation revisited : heterogeneity in capture-recapture and the role of external evidence ', Addiction, vol. 111, no. 3 . https://doi.org/10.1111/add.13222
Jones, H E, Welton, N J, Ades, A E, Pierce, M, Davies, W, Coleman, B, Millar, T & Hickman, M 2016, ' Problem drug use prevalence estimation revisited : heterogeneity in capture-recapture and the role of external evidence ', Addiction, vol. 111, no. 3, pp. 438-47 . https://doi.org/10.1111/add.13222
Jones, H E, Welton, N J, Ades, A E, Pierce, M, Davies, W, Coleman, B, Millar, T & Hickman, M 2016, ' Problem drug use prevalence estimation revisited : heterogeneity in capture-recapture and the role of external evidence ', Addiction, vol. 111, no. 3 . https://doi.org/10.1111/add.13222
BACKGROUND AND AIMS:Capture-recapture (CRC) analysis is recommended for estimating the prevalence of problem drug use or people who inject drugs (PWID). We aim to demonstrate how naïve application of CRC can lead to highly misleading results, and to
Autor:
Kirsty Roberts, William L. Irving, Peter Vickerman, Chris Metcalfe, John Macleod, Sharon Marlowe, Fiona H. Gordon, Peter Muir, Joanne Simon, Barbara Coleman, Jeremy Horwood, Matthew Hickman, Cherry-Ann Waldron, William Hollingworth, Graham I. Harrison
Publikováno v:
Roberts, K A, Macleod, J, Metcalfe, C, Simon, J, Horwood, J, Hollingworth, W, Marlowe, S, Gordon, F H, Muir, P, Coleman, B, Vickerman, P, Waldron, C-A, Irving, W L & Hickman, M 2016, ' Hepatitis C – Assessment to Treatment Trial (HepCATT) in primary care : study protocol for a cluster randomised controlled trial ', Trials, vol. 17, 366 . https://doi.org/10.1186/s13063-016-1501-3
Trials
Trials
Background Public Health England (PHE) estimates that there are upwards of 160,000 individuals in England and Wales with chronic hepatitis C virus (HCV) infection, but until now only around 100,000 laboratory diagnoses have been reported to PHE and o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2363b6f953eacac599a7b2c804117d3a
https://research-information.bris.ac.uk/ws/files/80895154/art_3A10.1186_2Fs13063_016_1501_3.pdf
https://research-information.bris.ac.uk/ws/files/80895154/art_3A10.1186_2Fs13063_016_1501_3.pdf
Autor:
Lee M. Krug, Barbara Coleman, Barbara Pizzo, Lauren Lastinger, Teresa Seeger, Christopher G. Azzoli, Amy Farmer, Charles M. Rudin, Mark G. Kris, Erin Moore, Naiyer A. Rizvi, Vincent A. Miller, Leslie B. Tyson, Ennapadam Venkatraman, Megan Dunne
Publikováno v:
Journal of Thoracic Oncology. 2(7):638-644
Introduction We undertook this phase II study to measure postoperative drug delivery and toxicity of cisplatin plus docetaxel in patients with resected stage I-III non-small cell lung cancer. Methods The primary endpoint was amount of cisplatin deliv
Autor:
Rebecca Deering Brose, David J. Cutler, Aravinda Chakravarti, Teresa Lai, Barbara Coleman, Scott M. Blackman, Kathleen M. Naughton, Julie Hoover-Fong, Dan E. Arking, M. Daniele Fallin, Kristen West, Suzanne E. Beck, Garry R. Cutting, Ada Hamosh, Rita McWilliams, Marilyn Algire
Publikováno v:
Gastroenterology. 131:1030-1039
Background & Aims: Neonatal intestinal obstruction (meconium ileus [MI]) occurs in 15% of patients with cystic fibrosis (CF). Our aim was to determine the relative contribution of genetic and nongenetic modifiers to the development of this major comp
Autor:
Barbara Coleman, Kristen A. Marrone, Gary L. Rosner, David S. Ettinger, Patrick M. Forde, Julie R. Brahmer, Xian Zhou
Publikováno v:
Journal of Thoracic Oncology. 12:S893